CAPTRUST Financial Advisors’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-25,997
| Closed | -$1.05M | – | 2192 |
|
|
2023
Q4 | $1.05M | Sell |
25,997
-4,273
| -14% | -$173K | ﹤0.01% | 1234 |
|
|
2023
Q3 | $798K | Buy |
30,270
+10,845
| +56% | +$286K | ﹤0.01% | 1334 |
|
|
2023
Q2 | $334K | Buy |
+19,425
| New | +$334K | ﹤0.01% | 1890 |
|
|
2022
Q3 | – | Sell |
-1,034
| Closed | -$9K | – | 2252 |
|
|
2022
Q2 | $9K | Sell |
1,034
-100
| -9% | -$870 | ﹤0.01% | 3788 |
|
|
2022
Q1 | $12K | Buy |
1,134
+573
| +102% | +$6.06K | ﹤0.01% | 3694 |
|
|
2021
Q4 | $9K | Buy |
561
+114
| +26% | +$1.83K | ﹤0.01% | 3763 |
|
|
2021
Q3 | $21K | Buy |
447
+268
| +150% | +$12.6K | ﹤0.01% | 3120 |
|
|
2021
Q2 | $11K | Sell |
179
-25
| -12% | -$1.54K | ﹤0.01% | 3483 |
|
|
2021
Q1 | $13K | Buy |
+204
| New | +$13K | ﹤0.01% | 3273 |
|